This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to approve September quarter and half-year results on 3 November 2026
BODALCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Bodal Chemicals will hold a Board meeting on 3 November 2026 to approve standalone and consolidated unaudited results for the quarter and half-year ended 30 September 2026. Trading in company securities is closed until 48 hours after the results are declared, with reopening planned from 6 November 2026. No financial figures were provided.
No earnings figures were disclosed. Shareholders may see volatility around the 3 November results and the trading window reopening on 6 November.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹863.4 Cr | ₹480.5 Cr | +79.7% |
| Operating profit | ₹69.41 Cr | −₹14.34 Cr | turned positive |
| Profit after tax | ₹81.44 Cr | ₹5.99 Cr | +1,259.0% |
| EBITDA margin | 12.4% | 4.8% | +7.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.